Pascha Chafin, NP
Vascular Surgery · Atlanta, GANPI 1457604993
Payments from drug & device makers
Across 54 payments — averaging $24.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alnylam Pharmaceuticals Inc.$304
- Merck$185
- Boehringer Ingelheim$102
- Novartis$98
- Medtronic$74
- Edwards Lifesciences$57
- plus $485 from 18 others
What the payments were for
- Food & beverage$1,25496%
- Education$504%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 12 | $304 |
| Merck | 8 | $185 |
| Boehringer Ingelheim | 4 | $102 |
| Novartis | 4 | $98 |
| Medtronic | 3 | $74 |
| Edwards Lifesciences | 2 | $57 |
| Esperion Therapeutics, Inc. | 2 | $51 |
| W. L. Gore & Associates, Inc. | 1 | $50 |
| Amgen | 2 | $48 |
| Boston Scientific | 1 | $39 |
| Bayer | 1 | $33 |
| Bard Peripheral Vascular, Inc. | 2 | $31 |
| Abbott | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Novo Nordisk | 1 | $24 |
| Ionis Pharmaceuticals, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $22 |
| Scpharmaceuticals Inc. | 1 | $21 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $21 |
| AstraZeneca | 1 | $19 |
| BD | 1 | $17 |
| Lemaitre Vascular, Inc. | 1 | $15 |
| Flowphysix Inc | 1 | $11 |
| Cvrx, Inc. | 1 | $10 |
How this compares
$1,304 in reported general payments places this provider in the 15th percentile of 176 vascular surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular surgery in Atlanta
- Siddharth PatelAtlanta$381K
- Yazan DuwayriAtlanta$284K
- Charles RossAtlanta$178K
- Andrew UnzeitigAtlanta$96K
- Jaime Benarroch GampelAtlanta$84K
- Walaya Methodius-RayfordAtlanta$79K
- Christopher RamosAtlanta$48K
- Peter H DoublerAtlanta$47K
- Jorge CorsoAtlanta$41K
- Anumeha WhisenhuntAtlanta$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.